New York City Health and Hospitals Corporation
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, New York City Health and Hospitals Corporation sits in the top decile of US sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count).
New York City Health and Hospitals Corporation: 17 sponsored US clinical trials, none currently recruiting.
New York City Health and Hospitals Corporation sponsors 17 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 12 completed. 3 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Diffuse Apneic Oxygenation, with 1 trials.
Top-decile sponsor footprint
New York City Health and Hospitals Corporation ranks in the top decile of sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
12 of 15 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
17 total, page 1 of 1
Online MedEd Intern Bootcamp: Hybrid (Online+Live) Training for First Year Residents
NCT06970340
Online MedEd Intern Bootcamp: Online Training for First Year Residents
NCT06977243
Assessment of Visual Function in Ophthalmic Disorders Using Virtual Visual Field Analysis
NCT04110015
Music Therapy for Pain Management for Minor Procedures in Neonates.
NCT04313179
Point-of-Care Ultrasound Educational Initiative for Insect Bites
NCT03619746
The Effect of Cetirizine on Bronchoconstriction
NCT03340740
Weight-Based Torsemide Dosing in Subjects With Heart Failure
NCT03187509
Evaluation of Discomfort Associated With Scleral Depression During Retina Examinations
NCT04115917
End-tidal Oxygen Can Reliably Predict the Arterial Partial Pressure of Oxygen Among Emergency Department Patients
NCT03842306
Comfort Comparison of Intravitreal Injection Eyelid Retraction Techniques
NCT04144985
Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge
NCT03369847
EmergeNcy Department Apneic Oxygenation Versus Usual Care During Rapid Sequence Intubation
NCT02737917
Nitrous Oxide Use in Minor Procedures
NCT01911351
Integrating HIV and Hepatitis C Screening in an Urban Emergency Department
NCT03252483
Effect of Adjunctive Misoprostol Treatment on Blood Loss at Vaginal Delivery
NCT02411916
Assessment of Bullying in Children
NCT01439763
A Patient Centered Intervention to Improve Health and Reduce Medicaid Costs
NCT01602848
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 3 |
Therapeutic Areas
How the New York City Health and Hospitals Corporation archive is shaped
17 indexed studies, none listed as recruiting (0% open); 12 completed (71%).
Phase mix: 3 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Diffuse Apneic Oxygenation (1 trial), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
New York City Health and Hospitals Corporation: archived-pipeline peers nationwide
Peers matched on 17 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
New York City Health and Hospitals Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 17 archived trials
- Achieve Life Sciences · 17 trials · 0% recruiting
- BioDelivery Sciences International · 17 trials · 6% recruiting
- Chugai Pharmaceutical · 17 trials · 24% recruiting
- ConvaTec · 17 trials · 18% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this New York City Health and Hospitals Corporation page
17 registered trials is a research-attention snapshot, not an endorsement of New York City Health and Hospitals Corporation or any single study.
- None of New York City Health and Hospitals Corporation's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Diffuse Apneic Oxygenation is the condition New York City Health and Hospitals Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Diffuse Apneic Oxygenation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
New York City Health and Hospitals Corporation pipeline card: 17 registered trials from official public datasets.Report a data error.